Long-term administering low anticoagulant activity heparin can lessen rat hepatic fibrosis induced by either CCl4 or porcine serum injection

Hepatology Research

Volumn 36, Issue 2, 2006, Pages 115-123

  Li, Wencai ^a,b   Zhang, Jinsheng ^a   Huang, Quangcun ^a   Zhu, Hongguang ^a   Zhang, Xuerong ^a  

^a FUDAN UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Activator protein 1; Extracellular signal regulated kinase; Liver fibrosis; Low anticoagulant activity heparin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLOBULIN; HEPARIN; HYDROXYPROLINE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR PROTEIN; PLATELET DERIVED GROWTH FACTOR BB; SODIUM CHLORIDE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BIOCHEMISTRY; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER FIBROSIS; LONG TERM CARE; MALE; MICROSCOPY; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STELLATE CELL; SWINE; WESTERN BLOTTING;

EID: 33749239667     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2006.07.004     Document Type: Article

References (40)

1. Musser J.H., Fugedi P., and Anderson M.B. Carbohydrate-based therapeutics. In: Wolff M.E. (Ed). Burger's medicinal chemistry and drug discovery. 5th ed. vol. I (1995), John Wiley & Sons, Inc., New York Chichester Brisbane Toronto Singapore 922-925
2. Samuel Z., Goldhaber M.D., Alexander G.G., and Turpie M.D. Prevention of venous thromboembolism among hospitalized medical patients. Circulation 111 (2005) 1-3
3. Epstein N.E. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery. Surg Neurol 64 (2005) 295-301
4. Hyers T.M. Heparin and other rapidly acting anticoagulants. Semin Vasc Surg 18 (2005) 130-133
5. Merli G. Anticoagulants in the treatment of deep vein thrombosis. Am J Med 118 Suppl 8A (2005) 13S-20S
6. Paoli G., Merlini P.A., and Ardissino D. Direct thrombin inhibitors for the treatment of acute coronary syndromes and during percutaneous coronary interventions. Curr Pharm Des 11 (2005) 3919-3929
7. Ruoslahti E., and Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 64 (1991) 867-869
8. Jessell T.M., and Melton D.A. Diffusible factors in vertebrate embryonic induction. Cell 68 (1992) 257-270
9. Mizuno K., Inoue H., Hagiya M., et al. Heparin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J Biol Chem 296 (1994) 1131-1136
10. Floege J., Eng E., Young B.A., Couser W.G., and Johnson R.J. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43 (1993) 369-380
11. Castellot Jr. J.J., Cochran D.L., and Karnovsky M.J. Effect of heparin on vascular smooth muscle cells. I. Cell metabolism. J Cell Physiol 124 (1985) 21-28
12. Li W., Zhang J., Huang G., Zhu H., Zhang X., and Zhang Y. Effects of heparin on the growth, extracellular matrix and matrix metalloproteinase gene expression in rat hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi (Chin J Hepatol) 8 (2000) 200-202
13. Gambaro G., Venturini A.P., Noonan D.M., et al. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int 46 (1994) 797-806
14. Gunther A., Lubke N., Ermert M., et al. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 168 (2003) 1358-1365
15. Fang N.X., and Zhang T.M. Studies of heparin with low anticoagulant activity. Acta Acad Med ShanDong 23 (1985) 20-25
16. Yang L.B., and Zhang T.M. Studies on low molecular weight heparin from low anticoagulant activity heparin. Chin J Pharm 21 (1990) 399-401
17. Abdel-Salam O.M., Baiuomy A.R., Ameen A., and Hassan N.S. A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat. Pharmacol Res 51 (2005) 59-67
18. Chen C., Zhang J., Li J., Huang G., and Shi J. Hydrodynamic-based in vivo transfection of retinoid X receptor-α gene can enhance vitamin A-induced attenuation of liver fibrosis in mice. Liver Int 24 (2004) 679-686
19. Weiner F.R., Blaner W.S., Czaja M.J., Shah A., and Geerts A. Ito cell expression of a nuclear retinoic acid receptor. Hepatology 15 (1992) 336-342
20. Sambrook J., and Russell D.W. Molecular cloning, a laboratory manual. 3rd ed. vol. III (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York p. 15.35
21. Schreiber E., Matthias P., Muller M.M., and Schaffner W. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucl Acids Res 17 (1989) 6419
22. Bergqvist D. Low-molecular-weight heparin for the prevention of postoperative venous thromboembolism after abdominal surgery: a review. Curr Opin Pulm Med 11 (2005) 392-397
23. Bhunchet E., and Wake K. Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis. Hepatology 16 (1992) 1452-1473
24. Bhunchet E., and Fujieda K. Capillarization and venularization of hepatic sinusoids in porcine serum-inducedrat liver fibrosis: a mechanism to maintain liver blood flow. Hepatology 18 (1993) 1450-1458
25. Baba Y., Saeki K., Onodera T., and Doi K. Serological and immunohistochemical studies on porcine-serum-induced hepatic fibrosis in rats. Exp Mol Pathol 79 (2005) 229-235
26. Hyers T.M. Heparin and other rapidly acting anticoagulants. Semin Vasc Surg 18 (2005) 130-133
27. Wright T.C., Pukac L.A., Castellot J.J., et al. Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc Natl Acad Sci USA 86 (1989) 3199-3203
28. Ferrao A.V., and Mason R.M. The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts. Biochim Biophys Acta 1180 (1993) 225-230
29. Liu X., Zhang J., and Zhang Y. Effects of platelet-derived growth factor on the proliferation of hepatic stellate cells and their expressions of genes of collagens and platelet-derived growth factor. Zhonghua Bing Li Xue Za Zhi (Chin J Pathol) 29 (2000) 27-29
30. Gao R., Ball D.K., Perbal B., and Brigstock D.R. Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J Hepatol 40 (2004) 431-438
31. Brenner D.A. Signal transduction during liver regeneration. J Gastroenterol Hepatol 13 Suppl (1998) S93-S95
32. Karin M., Liu Z., and Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 9 (1997) 240-246
33. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270 (1995) 16483-16486
34. Fan WH, Karnovsky M. Heparin inhibits endothelial apoptosis via FAS-dependent and -independent pathways. FASEB J 2003;17:Abstract No.171.
35. Ishikawa Y., and Kitamura M. Inhibition of glomerular cell apoptosis by heparin. Kidney Int 56 (1999) 954-963
36. Deepa P.R., and Varalakshmi P. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptic DNA damage in adriamycin-induced cardiac and renal toxicology. Toxicology 217 (2006) 176-183
37. Linhardt R.J. Heparin-induced cancer cell death. Chem Biol 11 (2004) 420-422
38. Tan E.M., Dodge G.R., Sorger T., et al. Modulation of extracellular matrix gene expression by heparin and endothelialcell growth factor in human smooth muscle cells. Lab Invest 64 (1991) 474-482
39. Hitraya E.G., Tan E.M., Rudnicka L., and Jimenez S.A. Expression of extracellular matrix genes in adult human dermal microvascular endothelial cells and their regulation by heparin and endothelial cell mitogens. Lab Invest 73 (1995) 393-402
40. Asselot-Chapel C., Combacau L., Labat-Robert J., and Kern P. Expression of fibronectin and interstitial collagen genes in smooth muscle cells: modulation by low molecular weight heparin fragments and serum. Biochem Pharmacol 49 (1995) 653-659